2000
DOI: 10.1016/s0014-2999(00)00367-8
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective activity of chemokines against N-methyl-d-aspartate or β-amyloid-induced toxicity in culture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

9
84
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 113 publications
(94 citation statements)
references
References 11 publications
9
84
0
Order By: Relevance
“…39,40 Interestingly, we and others have observed that MIP-1b and RANTES also reduce neuronal death owing to direct excitotoxic insult by NMDA, which is also consistent with a direct effect of these CCR5 ligands on neurons. 36,41 Our neurotoxicity experiments on cerebrocortical cultures from CCR5 KO mice demonstrate a pivotal role for this receptor in neuroprotection. Interestingly, the CCR5 ligands RANTES and MIP-1a/b have been found to be highly expressed in cerebrospinal fluid (CSF) of neurocognitively intact HIV-infected individuals, whereas the same chemokines were drastically diminished in the CSF of cognitively impaired AIDS patients.…”
Section: Discussionmentioning
confidence: 82%
“…39,40 Interestingly, we and others have observed that MIP-1b and RANTES also reduce neuronal death owing to direct excitotoxic insult by NMDA, which is also consistent with a direct effect of these CCR5 ligands on neurons. 36,41 Our neurotoxicity experiments on cerebrocortical cultures from CCR5 KO mice demonstrate a pivotal role for this receptor in neuroprotection. Interestingly, the CCR5 ligands RANTES and MIP-1a/b have been found to be highly expressed in cerebrospinal fluid (CSF) of neurocognitively intact HIV-infected individuals, whereas the same chemokines were drastically diminished in the CSF of cognitively impaired AIDS patients.…”
Section: Discussionmentioning
confidence: 82%
“…IL-8 is an ELR-positive (i.e., Glu-Leu-Arg motif-containing) ␣ chemokine that is principally recognized for its role as a chemotactic factor for neutrophils (Yasumoto et al, 1992), and levels of IL-8 rise dramatically in the CSF of patients with bacterial meningitis (Spanaus et al, 1997), as well as after brain injury, ischemia, and stroke (Tarkowski et al, 1997;Whalen et al, 2000). IL-8 may also play other roles in the CNS because it has been shown to provide trophic support for specific neuronal populations against a variety of toxic insults (Bruno et al, 2000). Conversely, IP-10 is an ELR-negative (i.e., contains no Glu-Leu-Arg motif) ␣ chemokine with known chemotactic effects on T cells and monocytes, as well as antiviral, anti-angiogenic, and anti-tumor properties (Luster and Leder, 1993;Angiolillo et al, 1995;Ben-Baruch et al, 1995).…”
Section: Discussionmentioning
confidence: 99%
“…9 Interestingly, as alluded to above, certain chemokines have been shown to protect neurons, even though the virus does not productively infect neurons. In particular, b-chemokines (acting on CCR5 receptors) and fractalkine prevent gp120-induced neuronal apoptosis in vitro, 81,109,194 and, similarly, some b-chemokines can ameliorate NMDAR-mediated neurotoxicity. 194 Additionally, HIV-infected patients with higher CSF concentrations of the b-chemokines MIP-1a/b and RANTES performed better on neuropsychological measures than those with low or undetectable levels.…”
mentioning
confidence: 98%
“…In particular, b-chemokines (acting on CCR5 receptors) and fractalkine prevent gp120-induced neuronal apoptosis in vitro, 81,109,194 and, similarly, some b-chemokines can ameliorate NMDAR-mediated neurotoxicity. 194 Additionally, HIV-infected patients with higher CSF concentrations of the b-chemokines MIP-1a/b and RANTES performed better on neuropsychological measures than those with low or undetectable levels. 195 These findings support the hypothesis that selected b-chemokines may represent a potential treatment modality for HAD.…”
mentioning
confidence: 98%